Check out PRESS RELEASE MethylGene Presents Preclinical Data for its Clinical

[Guest guest]

Fungal infections are often treated with a class of drugs called azoles.

Infections caused by certain Candida and Aspergillus species can be especially

difficult to manage medically. Aspergillosis has a high mortality rate in

immunocompromised patients. In 2004, the market for systemic antifungal drugs

was

estimated to be US $5 billion worldwide with azole sales being a major

contributor.

_http://www.marketwire.com/mw/release_html_b1?release_id=257352_

(http://www.marketwire.com/mw/release_html_b1?release_id=257352)

_PRESS RELEASE MethylGene Presents Preclinical Data for its Clinical

Candidate MGCD290-An Antifungal Histone Deacetylase Inhib._ (h

ttp://www.marketwire.com/mw/release_html_b1?release_id=257352)

Sharon Kramer

************************************** See what's free at http://www.aol.com.